These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 32217462)
21. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation. Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012 [TBL] [Abstract][Full Text] [Related]
22. G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism. Lee YS; Saxena V; Bromberg JS; Scalea JR Cell Immunol; 2021 Jun; 364():104346. PubMed ID: 33848847 [TBL] [Abstract][Full Text] [Related]
23. TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression. Cao P; Sun Z; Zhang F; Zhang J; Zheng X; Yu B; Zhao Y; Wang W; Wang W Front Immunol; 2022; 13():919674. PubMed ID: 35874674 [TBL] [Abstract][Full Text] [Related]
24. Triptolide promotes differentiation of human monocytes into immunosuppressive MDSCs. Wang H; Yang H; Zhang X; Zhou X Cell Immunol; 2024; 401-402():104836. PubMed ID: 38776753 [TBL] [Abstract][Full Text] [Related]
25. Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells. Zhou J; Yao Y; Shen Q; Li G; Hu L; Zhang X J Cancer Res Clin Oncol; 2017 Aug; 143(8):1371-1380. PubMed ID: 28321548 [TBL] [Abstract][Full Text] [Related]
26. Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation. Scalea JR; Lee YS; Davila E; Bromberg JS Transplantation; 2018 Mar; 102(3):359-367. PubMed ID: 29189485 [TBL] [Abstract][Full Text] [Related]
27. The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation. Zhang C; Wang S; Yang C; Rong R J Immunol Res; 2016; 2016():4986797. PubMed ID: 27868073 [TBL] [Abstract][Full Text] [Related]
28. Accumulation of High Levels of Monocytic Myeloid-Derived Suppressor Cells Enhances Graft Survival in Almost-Tolerant Kidney Transplant Recipients. Du XX; Guo YL; Zhao YP; Yang M; Chang S; Liu B; Cai LJ; Chen ZK Transplant Proc; 2018 Dec; 50(10):3314-3320. PubMed ID: 30577201 [TBL] [Abstract][Full Text] [Related]
29. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation. Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747 [TBL] [Abstract][Full Text] [Related]
30. Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation. Iske J; Cao Y; Roesel MJ; Shen Z; Nian Y Cytotherapy; 2023 Aug; 25(8):789-797. PubMed ID: 37204374 [TBL] [Abstract][Full Text] [Related]
31. Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation. Ochando J; Conde P; Utrero-Rico A; Paz-Artal E Front Immunol; 2019; 10():374. PubMed ID: 30894860 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment. Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P Front Immunol; 2020; 11():585214. PubMed ID: 33613512 [TBL] [Abstract][Full Text] [Related]
33. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937 [TBL] [Abstract][Full Text] [Related]
34. Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy. Zhang W; Li J; Qi G; Tu G; Yang C; Xu M J Transl Med; 2018 Jan; 16(1):19. PubMed ID: 29378596 [TBL] [Abstract][Full Text] [Related]
35. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Zhang W; Liang S; Wu J; Horuzsko A Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352 [TBL] [Abstract][Full Text] [Related]
36. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. De Cicco P; Ercolano G; Ianaro A Front Immunol; 2020; 11():1680. PubMed ID: 32849585 [TBL] [Abstract][Full Text] [Related]
37. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway. Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139 [TBL] [Abstract][Full Text] [Related]
38. Induction of transplantation tolerance through regulatory cells: from mice to men. Ferrer IR; Hester J; Bushell A; Wood KJ Immunol Rev; 2014 Mar; 258(1):102-16. PubMed ID: 24517428 [TBL] [Abstract][Full Text] [Related]
39. Hepatic immune tolerance induced by hepatic stellate cells. Hsieh CC; Hung CH; Lu L; Qian S World J Gastroenterol; 2015 Nov; 21(42):11887-92. PubMed ID: 26576077 [TBL] [Abstract][Full Text] [Related]
40. Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity. Scheurer J; Reisser T; Leithäuser F; Messmann JJ; Holzmann K; Debatin KM; Strauss G Clin Exp Immunol; 2020 Dec; 202(3):407-422. PubMed ID: 32681646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]